- About Us
- Nano-Social Network
- Nano Consulting
- My Account
September 10th, 2004
Research and Markets has announced the addition of Nanobiotechnology: Opportunities and Technical Analysis to their offering.
Several industries are hindered by the limitations of current technologies. In medicine, clinical diagnostics are often costly and time-consuming. Additionally, most therapeutics lack specificity, and therefore are limited in efficacy and safety. In life science research, the drug discovery process continues to be slowed by existing imaging and screening techniques. Nanobiotechnology promises to provide novel tools and materials that address current technological limitations, and thereby holds great promise for significant advances in both medicine and life science research.
|Related News Press|
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017